Key topics of discussion will include: 
1) BACE1 inhibitors and/or γ-secretase modulators for reducing amyloid deposition 
2) Active and passive vaccination for enhancing clearance of amyloid plaques
3) Vaccines for reducing tau pathology
4) Antisense approaches for AD, PD and ALS therapy 
5) Neural stem cell approaches for neurodegeneration
6) Inflammatory modulators for neurodegeneration.